Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Bone Marrow Transplantation

• Publication date

  2003-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1704261PMID 14625581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.

  2002cited by this paper
• Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation.

  2002cited by this paper
• Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation.

  2001cited by this paper
• Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.

  2001cited by this paper
• Frequent detection of rising cytomegalovirus antigenemia after allogeneic stem cell transplantation following a regimen containing antithymocyte globulin.

  2001cited by this paper
• Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan.

  2001cited by this paper
• Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study

  2001cited by this paper
• Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

  2001cited by this paper
• Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation.

  2000cited by this paper
• Risk factors for severe hemorrhagic cystitis following BMT

  1999cited by this paper
• Haemorrhagic cystitis: incidence and risk factors in a transplant population using hyperhydration

  1999cited by this paper
• Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.

  1998cited by this paper
• Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

  1998cited by this paper
• High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

  1998cited by this paper
• Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children

  1998cited by this paper
• Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.

  1997cited by this paper
• A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia

  1996cited by this paper
• Efficacy of Mesna for Prevention of Hemorrhagic Cystitis After High-Dose Cyclophosphamide Therapy

  1995cited by this paper
• 1994 Consensus Conference on Acute GVHD Grading.

  1995cited by this paper
• Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation.

  1995cited by this paper
• Hemorrhagic cystitis inbone marrow transplantation

  1994cited by this paper
• Haemorrhagic cystitis in paediatric bone marrow transplant patients: an association with infective agents, GVHD and prior cyclophosphamide.

  1994cited by this paper
• Hemorrhagic cystitis in bone marrow transplantation.

  1994cited by this paper
• HEMORRHAGIC CYSTITIS AFTER BONE MARROW TRANSPLANTATION RISK FACTORS AND COMPLICATIONS

  1993cited by this paper
• Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults.

  1993cited by this paper
• Management of fever in patients with cancer and treatment-induced neutropenia.

  1993cited by this paper
• Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

  1991cited by this paper
• Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.

  1990cited by this paper
• Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.

  1990cited by this paper
• Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome.

  1989cited by this paper
• Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation.

  1989cited by this paper
• Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.

  1987cited by this paper
• Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen.

  1987cited by this paper
• Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

  1987cited by this paper
• Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.

  1987cited by this paper
• Hemorrhagic cystitis--a manifestation of graft versus host disease?

  1987cited by this paper
• Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants.

  1986cited by this paper
• Adenovirus infections in patients undergoing bone-marrow transplantation.

  1985cited by this paper
• Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.

  1983cited by this paper
• Prevention of cyclophosphamide-induced hemorrhagic cystitis.

  1982cited by this paper
• Busulfan-induced hemorrhagic cystitis.

  1981cited by this paper

• Effectiveness of hyperbaric oxygen therapy for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation

  2021cites this paper
• Pretransplant BK Virus-Specific T-Cell-Mediated Immunity and Serotype Specific Antibodies May Have Utility in Identifying Patients at Risk of BK Virus-Associated Haemorrhagic Cystitis after Allogeneic HSCT

  2021cites this paper
• Pretransplant BK virus-specific T-cell-mediated immunity and serotype specific antibodies may have utility in identifying patients at risk for BK virus associated haemorrhagic cystitis after allogeneic HSCT

  2021cites this paper
• Prophylaxis and Management of Infectious Complications After Hematopoietic Cell Transplantation

  2019cites this paper
• Pharmacological Options for Viral Induced Hemorrhagic Cystitis Management: A Review of the Literature

  2019cites this paper
• CUA best prACtiCe report Canadian Urological Association Best Practice Report: Pediatric hemorrhagic cystitis

  2019cites this paper
• Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients?

  2018cites this paper
• Viral‐induced Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplant

  2017cites this paper
• Interventions for preventing hemorrhagic cystitis in patients undergoing hematopoietic stem cell transplantation

  2016cites this paper
• Reactivation of polyomavirus in the genitourinary tract is significantly associated with severe GvHD and oral mucositis following allogeneic stem cell transplantation

  2016cites this paper
• Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival

  2015cites this paper
• Cytomegalovirus is a potential risk factor for late‐onset hemorrhagic cystitis following allogeneic hematopoietic stem cell transplantation

  2014cites this paper
• MONOGRAPHS – 104 other cell lines , such as primary human renal tubular epithelial cells and 293 TT human embry

  2014cites this paper
• MALARIA AND SOME POLYOMAVIRUSES (SV40, BK, JC, AND MERKEL CELL VIRUSES)

  2014cites this paper
• BK virus disease after allogeneic stem cell transplantation: a cohort analysis.

  2014cites this paper
• The polyomavirus puzzle: is host immune response beneficial in controlling BK virus after adult hematopoietic cell transplantion?

  2014cites this paper
• BK viremia precedes hemorrhagic cystitis in children undergoing allogeneic hematopoietic stem cell transplantation.

  2013cites this paper
• Urological management (medical and surgical) of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation

  2013cites this paper
• Exposure Data 1 . 1 Cell and tissue tropism

  2013cites this paper
• Recipient seropositivity for adenovirus type 11 (AdV11) is a highly predictive factor for the development of AdV11-induced hemorrhagic cystitis after allogeneic hematopoietic SCT

  2013cites this paper
• Different risk factors related to adenovirus- or BK virus-associated hemorrhagic cystitis following allogeneic stem cell transplantation.

  2012cites this paper
• Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children

  2011cites this paper
• Full myeloablative conditioning and an unrelated HLA mismatched donor increase the risk for BK virus-positive hemorrhagic cystitis in allogeneic hematopoetic stem cell transplanted patients.

  2011cites this paper
• Prevalence of viral infections and hemorrhagic cystitis in hematopoietic stem cell transplant recipients.

  2011cites this paper
• Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

  2010cites this paper
• Late onset hemorrhagic cystitis in a hematopoietic stem cell recipient: Treatment with intravesical hyaluronic acid

  2010cites this paper
• Cyclophosphamide and cancer: golden anniversary

  2009cites this paper
• BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts

  2008cites this paper
• Prevention and management of BK‐virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation – a systematic review and evidence‐based guidance for clinical management

  2008cites this paper
• HEMATOLOGIC CONDITIONS IN THE ICU

  2008cites this paper
• BK virus in hematopoietic stem cell transplantation recipients.

  2008cites this paper
• Hyperbaric oxygen should not be used in the management of hemorrhagic cystitis in patients with Fanconi anemia

  2007cites this paper
• Viruria in Adult Hemorrhagic Cystitis Patients Following Allogeneic Hematopoietic Stem Cell Transplantation and Implication of Antiviral Treatment

  2007cites this paper
• Reduced-intensity transplantation in the treatment of haematological malignancies: current status and future-prospects.

  2007cites this paper
• Critical care considerations of hematopoietic stem cell transplantation

  2006cites this paper
• Reduced-intensity conditioning for acute myeloid leukemia: is this strategy correct

  2006cites this paper
• The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen.

  2006cites this paper
• A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogeneic haematopoetic stem cell-transplanted patients.

  2006cites this paper
• Comparison between reduced intensity and conventional myeloablative allogeneic stem-cell transplantation in patients with hematologic malignancies aged between 50 and 59 years

  2005cites this paper
• Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm

  2005cites this paper
• Reduced-intensity conditioning regimens in malignant haematological diseases.

  2005cites this paper